Investing Profile

JeenJoo Kang

InvestorVCCEO
Venture Partner at The Column Group
thecolumngroup.com/team/San Francisco, California
Photo of JeenJoo Kang, Venture Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
809 CONNECTIONS
Caltech Network
56 CONNECTIONS
California Institute of Technology Network
21 CONNECTIONS
The Column Group Network
12 CONNECTIONS
The Column Group Network
12 CONNECTIONS
cb
The Column Group Venture Partner
$100K - $5.0M
$1.5M
3
$600M
CompanyStageDateRound SizeTotal Raised
Escient Pharmaceuticals
Series CNov 2022$120M
Series BSep 2020$78M
Series AMay 2018$40M
$240M
Co-investors: Andrew Schwab (5am Ventures), Jason P. Hafler (Sanofi Ventures)
Corporate Strategy, Sr. Associate FibroGen, Inc.Present
Project Management FibroGen, Inc.Present
Associate, Biotech Venture Capital The Column GroupPresent
Founding President Tenaya TherapeuticsPresent
Board Director Tenaya TherapeuticsPresent
Principal, Biotech Venture Capital The Column GroupPresent
Board Director Exonics TherapeuticsPresent
Board Director Escient PharmaceuticalsPresent
Partner The Column GroupPresent
Venture Partner The Column GroupPresent
Chief Executive Officer Appia BioPresent
Harvard University Bachelor’s Degree Chemistry
California Institute of Technology Doctor of Philosophy (Ph.D.) Chemical Biology
Caltech Doctor of Philosophy (Ph.D.) Chemical Biology
Sign in with Google →
Sign in with Google →